General cancer cell proliferation machinery

The term General cancer cell proliferation machinery refers to the collective set of biological processes and molecular components that enable malignant cells to undergo rapid, uncontrolled division. This machinery includes the core cell cycle regulators such as cyclin-dependent kinases (CDKs), the DNA replication apparatus including polymerases and topoisomerases, and the mitotic spindle assembly involving tubulin [1][2]. In oncogenesis, these systems are hijacked through the constitutive activation of growth factor signaling pathways (e.g., MAPK, PI3K/AKT) and the inactivation of tumor suppressor checkpoints like p53 and Rb [1][3]. Therapeutic strategies targeting this machinery range from traditional cytotoxic chemotherapies that damage DNA or disrupt microtubules to modern targeted therapies that inhibit specific kinases driving the cell cycle [2][4]. Because these proliferative mechanisms are also utilized by healthy tissues with high turnover, such as bone marrow and the intestinal lining, pharmacological intervention often results in significant systemic toxicities [5]. This entry is considered incorrect as a single target because it encompasses a vast array of distinct proteins and pathways rather than a specific molecule or receptor [1].

Other names

Cell cycle machineryProliferative signaling networkMitotic apparatusDNA replication machineryCancer growth signaling pathways

Inhibition of DNA synthesis and repair, disruption of microtubule assembly or disassembly during mitosis, and blockade of cyclin-dependent kinases to induce cell cycle arrest and apoptosis.